Labshake search
Citations for R&D Systems :
151 - 200 of 406 citations for n4 Benzoyl 5 methyldeoxycytidine since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ECFCs and PRECs were treated with 5 nM Fc Chimera (R&D Systems) or 100 ug/mL NRP-1 Antibody (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... and 5 ng/ml TGF-β1 (R&D Systems, Bio-Techne, Wiesbaden, Germany) for 72 hours.
-
bioRxiv - Cancer Biology 2022Quote: ... 5 μg/mL Tenascin-C (Cat no. 3358-TC-050, R&D Systems) coated ...
-
bioRxiv - Cell Biology 2024Quote: ... or recombinant FGF9 (5-25 ng/ml, R&D Systems, INC, Minneapolis, MN). After 24 ...
-
bioRxiv - Developmental Biology 2024Quote: ... cultures were maintained in media containing 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Bioengineering 2024Quote: ... 5 ng/mL R-Spondin1 (R-spo1; R&D systems; 4645-RS/CF), and 1% B27 supplement (Gibco ...
-
bioRxiv - Cell Biology 2024Quote: ... Primary antibodies used: mouse monoclonal anti-hSiglec-5 (R&D systems, 1:1000), rabbit anti-VCAM-1 polyclonal antibody (Santa Cruz ...
-
bioRxiv - Cell Biology 2024Quote: ... 5% BSA and VisUBlock Mouse on Mouse Blocking Reagent (R&D Systems, VB001). Primary and secondary antibodies were diluted in 0.1% saponin ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 5 ng mL-1 of IL-7 and IL-15 (R&D Systems). Regulatory T cells were activated at 1 x 106 cells mL-1 for 2 days in complete XVivo15 supplemented with magnetic Treg Xpander CTS Dynabeads (ThermoFisher ...
-
bioRxiv - Microbiology 2022Quote: ... 5 x106 transduced cells were stained with 1.25µg DPP4 antibody (R&D Systems AF1180) for one hour at room temperature ...
-
bioRxiv - Neuroscience 2020Quote: ... then labelled with and without anti-human LILRB2 (5 µg/mL; R&D Systems). The cells were washed with PBS (0.5% BSA ...
-
bioRxiv - Biophysics 2021Quote: ... AMPPNP PfK5ΔL6-MD was prepared by incubation with 5 mM AMPPNP (R&D Systems) for at least 5 mins at 4 °C ...
-
bioRxiv - Cell Biology 2022Quote: ... together with human vascular endothelial growth factor (hVEGF, 5 ng/ml; R&D Systems). Cardiac specification was induced by exposure of cells to StemPro-34 SF medium (Gibco ...
-
bioRxiv - Neuroscience 2021Quote: VEGF165b (3 – 30 ng; 5 µl; cat. #3045-VE-025, R&D System, USA), PlGF-2 (3 – 30 ng ...
-
bioRxiv - Cell Biology 2022Quote: ... 5 μg/ml heparin and 50 ng/ml BMP-4 (#5020BP, R&D System). Seventy-two hours after induction ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 5 ng/ml RANKL (R&D Systems Catalog #462-TEC-010; Lot # CWA2622011), which is the previously reported EC50 needed for primary bone marrow cell differentiation into osteoclasts ...
-
bioRxiv - Immunology 2023Quote: ... BMDMs were treated with recombinant mouse SPARCL1 (5-20 μg/ml, R&D system, #4547-SL ...
-
bioRxiv - Bioengineering 2023Quote: ... and further supplemented with 5 ng ml -1 of FGF-2 (R&D Systems). Medium was changed twice a week ...
-
bioRxiv - Microbiology 2024Quote: ... supplemented with 5% fetal bovine serum (FBS; R&D systems, Flower Branch, GA, USA) and 1% antibiotic-antimycotic (Gibco ...
-
bioRxiv - Cell Biology 2024Quote: ... containing 5 µg/ml rDLK1 resuspended in PBS (R&D Systems, #1144-PR-025) or PBS vehicle ...
-
bioRxiv - Molecular Biology 2023Quote: ... cells were treated with Idasanutlin (5 μM; R&D Systems, #12-35-22-07) or Doxorubicin (0.5 µM ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were permeabilized and stained with 5 μg/ml anti-BrdU (R&D Systems). Samples were imaged with a glycerol-immersion ACS_APO 20x/NA 0.60 objective (Leica ...
-
bioRxiv - Immunology 2023Quote: ... 1 ng/ml IL-12 and 5 ng/ml IL-15 (R&D Systems). Re-stimulation with irradiated (100 Gy) ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/ml IL-7 and 5 ng/ml IL-15 (R&D Systems). After 14 days ...
-
bioRxiv - Immunology 2022Quote: ... IL-4 (50 ng/ml) and TGF-β (5 ng/ml) (R&D Systems) for TH9 cells ...
-
bioRxiv - Molecular Biology 2022Quote: ... the transfected cells were treated with 5 ng/ml TGF-β1 (R&D Systems) for 24 hours ...
-
bioRxiv - Cancer Biology 2023Quote: ... purified sheep IgG (2 mg/mL for LRIG1 R&D Systems #5-001-A), and mouse IgG1-PE conjugate (10 uL for LGR5 ...
-
bioRxiv - Microbiology 2024Quote: ... supplemented with 5% fetal bovine serum (FBS; R&D systems, Flower Branch, GA, USA) and 1% antibiotic-antimycotic solution (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... 5) 10 ng/ml TGFβ1 (766-MB-005, R&D systems, Minneapolis, MN, US), 6 ...
-
bioRxiv - Molecular Biology 2024Quote: The FKBP12F36V-NPM1-ESCs were treated with dTAG-13 (R&D Systems, 6605/5) at 100nM for 3 days and DMSO was used as a control ...
-
bioRxiv - Microbiology 2024Quote: ... supplemented with 5% fetal bovine serum (FBS; R&D systems, Flower Branch, GA, USA) and a 1% antibiotic-antimycotic solution (Gibco ...
-
bioRxiv - Neuroscience 2024Quote: ... or 5 µg/mL of a recombinant human efnB2-Fc (R&D Systems, U.S.A.). Both recombinant proteins were pre-clustered with 10 µg/mL of an anti-human IgG antibody (Thermo Fisher ...
-
bioRxiv - Bioengineering 2024Quote: ... and rhIL-7 (5 ng ml−1, Cat: 207-IL-010, R&D Systems). 1 x 104 post-EMO cells were combined with 2.5 x 105 MS5-hDLL4 stromal cells per ATO in a 1.7 ml Eppendorf tube (up to 144 ATOs per tube ...
-
bioRxiv - Immunology 2022Quote: ... Primary B cell complete media also contains 5 ng/ml of BAFF (R&D Systems).
-
bioRxiv - Neuroscience 2021Quote: ... PlGF-2 (3 – 30 ng; 5 µl; cat.465-PL/CF, R&D System, USA), VEGF-E (3 – 30 ng ...
-
bioRxiv - Molecular Biology 2020Quote: Mice fibroblast cells (FLS) treated with 5 ng/mL recombinant human TNF (R&D Systems) for 16 hours were harvested at 95% confluence ...
-
bioRxiv - Neuroscience 2022Quote: ... the media was supplemented with 40 ng/ml 3,3’,5-triiodothronine (T3, R&D systems). The spheroids were maintained in spheroid media from day 70 until completion of the experiment with half-media changes every other day ...
-
bioRxiv - Cell Biology 2021Quote: ... Medium was changed to differentiation medium supplemented with 5 ng/ml VEGF (R&D Systems) and 5 µmol/L XAV (Stemgent) ...
-
bioRxiv - Cell Biology 2021Quote: ... medium was changed to differentiation medium supplemented with 5 ng/ml VEGF (R&D Systems). After Day 8 ...
-
bioRxiv - Developmental Biology 2021Quote: ... Media was changed to differentiation media supplemented with 5 ng/ml VEGF (R&D Systems) and 5 µmol/L XAV (Stemgent) ...
-
bioRxiv - Developmental Biology 2021Quote: ... media was changed to differentiation media supplemented with 5 ng/ml VEGF (R&D Systems). After day 8 ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 5% heat-inactivated fetal bovine serum (FBS) (R&D Systems, Minneapolis, MN, USA) and 5% Fetalgro® (Rocky Mountain Biologics ...
-
bioRxiv - Microbiology 2023Quote: ... Hyphae were incubated with soluble CD56 (5 µg/mL, R&D Systems, Minneapolis, MN, USA) or BSA (control ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were treated with 5 ng/mL recombinant human TGFβ1 (R&D Systems, 240-B) prepared according to the manufacture’s specifications ...
-
bioRxiv - Microbiology 2024Quote: ... BChE activity was analogously measured using 5 ng of recombinant human BChE (R&D Systems) and butyrylthiocholine iodide ...
-
bioRxiv - Immunology 2023Quote: ... 5 µg/ml of recombinant mouse Siglec-E-Fc chimera (R&D Systems, Cat. 5806) in 100 μl of buffer (10mM Tris-HCl (pH7.4) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Secondary antibody was added for ULBP 1 and 2/5/6 only (R&D Systems). Cells were then washed and fixed in 4% paraformaldehyde ...
-
bioRxiv - Immunology 2022Quote: ... neutralising anti-IFNγ or isotype control (mouse IgG2b, both 5 μg/mL, R&D Systems) were added to cultures ...
-
bioRxiv - Developmental Biology 2023Quote: ... gfCDM media was supplemented with 5 nM BMP-4 (R&D Systems, #314-BP-050), followed by 1/2 media change on d9 and d12 ...
-
bioRxiv - Pathology 2024Quote: ... Some cells then treated with 5 ng/mL TGFβ1 (cat#7666-MB, R&D Systems) and incubate for 24 hours ...